Abstract
With prompt administration of appropriate antimicrobial therapy and access to modern intensive care support, fatal pediatric melioidosis is very unusual. We describe cases of two children in whom the possibility of melioidosis was recognized relatively early, but who died of the disease, despite receiving optimal supportive care. We discuss the resulting implications for bacterial virulence factors in disease pathogenesis.
MeSH terms
-
Anti-Bacterial Agents / therapeutic use*
-
Australia
-
Burkholderia pseudomallei / drug effects
-
Burkholderia pseudomallei / isolation & purification
-
Child
-
Fatal Outcome
-
Humans
-
Intensive Care Units
-
Lincomycin / therapeutic use
-
Male
-
Melioidosis / drug therapy*
-
Meropenem
-
Papua New Guinea
-
Sulfamethoxazole / therapeutic use
-
Thienamycins / therapeutic use
-
Trimethoprim / therapeutic use
-
Vancomycin / therapeutic use
Substances
-
Anti-Bacterial Agents
-
Thienamycins
-
Vancomycin
-
Trimethoprim
-
Lincomycin
-
Meropenem
-
Sulfamethoxazole